NI
ANIP icon

Numeric Investors’s ANI Pharmaceuticals ANIP Stock Holding History

Numeric Investors’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-16,400
Closed -$1.09M – 1026
2016
Q3 		$1.09M Buy
16,400
+8,700
+113% +$544K 0.01% 594
2016
Q2 		$430K Buy
+7,700
New +$374K ﹤0.01% 779
2015
Q2 		– Sell
-12,000
Closed -$751K – 926
2015
Q1 		$751K Buy
+12,000
New +$730K 0.01% 545

Other funds holding ANIP

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Numeric Investors's ANIP Position: Q4 2016 in Review

Numeric Investors sold out of ANI Pharmaceuticals (ANIP) in Q4 2016, closing a stake of 16,400 shares — an estimated $1.09M sold.

Numeric Investors first reported a position in ANIP in Q1 2015 and held it in 3 quarters. The position peaked at $1.09M in Q3 2016. 157 funds tracked by Wall St. Rank hold ANIP as of Q4 2016.

  • Numeric Investors reported no remaining ANI Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Numeric Investors sold 16,400 ANI Pharmaceuticals shares in Q4 2016, an estimated $1.09M.
  • Numeric Investors first reported a position in ANI Pharmaceuticals in Q1 2015 and held it in 3 quarters.
  • Numeric Investors's ANI Pharmaceuticals position peaked at $1.09M in Q3 2016.
  • 157 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2016.

Based on Numeric Investors's 13F filing for Q4 2016, filed 13 Feb 2017.